Results 351 to 360 of about 2,830,257 (398)
Some of the next articles are maybe not open access.
Obesity, migraine, and chronic migraine
Neurology, 2007Migraine and obesity are associated in several ways. First, both are prevalent and disabling disorders influenced by genetic and environmental risk factors. Second, migraine with aura, as obesity, seems to be a risk factor for cardiovascular events. Finally, large population-based studies suggest that obesity is a risk factor for chronic migraine after
Bigal, Marcelo E +3 more
openaire +3 more sources
Cephalalgia, 2020
Background This study reports the long-term safety and efficacy of erenumab in chronic migraine patients. Methods This was a 52-week open-label extension study of a 12-week double-blind treatment phase study.
S. Tepper +9 more
semanticscholar +1 more source
Background This study reports the long-term safety and efficacy of erenumab in chronic migraine patients. Methods This was a 52-week open-label extension study of a 12-week double-blind treatment phase study.
S. Tepper +9 more
semanticscholar +1 more source
Proposed new diagnostic criteria for chronic migraine
Cephalalgia, 2020Introduction ICHD-3 criteria for chronic migraine (CM) include a mixture of migraine and tension-type-like headaches and do not account for patients who have a high frequency of migraine but no other headaches.
M. A. Chalmer +5 more
semanticscholar +1 more source
Cephalalgia, 2020
Background and purpose An estimated 2.5–3.1% of people with episodic migraine develop chronic migraine in a year. Several risk factors are associated with an increased risk for this transformation.
Jingjing Xu, Fanyi Kong, D. Buse
semanticscholar +1 more source
Background and purpose An estimated 2.5–3.1% of people with episodic migraine develop chronic migraine in a year. Several risk factors are associated with an increased risk for this transformation.
Jingjing Xu, Fanyi Kong, D. Buse
semanticscholar +1 more source
Journal of Clinical Neuroscience, 2004
A series of 16 subjects is described who presented with chronic vertigo that was thought to be migrainous in nature. The vertigo occurred on a daily basis and had been present for six months or more. Common symptoms included motion-induced dizziness, positional vertigo and motion sensitivity. Investigations were frequently normal apart from the finding
openaire +2 more sources
A series of 16 subjects is described who presented with chronic vertigo that was thought to be migrainous in nature. The vertigo occurred on a daily basis and had been present for six months or more. Common symptoms included motion-induced dizziness, positional vertigo and motion sensitivity. Investigations were frequently normal apart from the finding
openaire +2 more sources
Cephalalgia, 2020
Background Previous voxel- or surface-based morphometric analysis studies have revealed alterations in cortical structure in patients with chronic migraine, yet with inconsistent results.
K. Lai +5 more
semanticscholar +1 more source
Background Previous voxel- or surface-based morphometric analysis studies have revealed alterations in cortical structure in patients with chronic migraine, yet with inconsistent results.
K. Lai +5 more
semanticscholar +1 more source
Serological Biomarkers of Chronic Migraine
Current Pain and Headache Reports, 2023Chronic migraine (CM) is a chronic form of migraine that differs from episodic migraine (EM) in terms of prevalence, comorbidities, response to treatment, and biomarkers. The aim of this review was to summarize the recent findings on serological biomarkers of CM.Neuronal, inflammatory, and vascular markers have been investigated to assess their ...
Soomi Cho, Min Kyung Chu
openaire +2 more sources
Headache, 2020
To assess the effectiveness, safety, and tolerability of erenumab in a real‐life migraine population, while trying to identify responsiveness predictors.
P. Barbanti +14 more
semanticscholar +1 more source
To assess the effectiveness, safety, and tolerability of erenumab in a real‐life migraine population, while trying to identify responsiveness predictors.
P. Barbanti +14 more
semanticscholar +1 more source
Journal of Pain & Palliative Care Pharmacotherapy, 2020
Erenumab is a monoclonal antibody that mediates calcitonin-gene-related peptide (CGRP), a pro-inflammatory polypeptide implicated in migraine pathology, by targeting its receptor.
M. Armanious +3 more
semanticscholar +1 more source
Erenumab is a monoclonal antibody that mediates calcitonin-gene-related peptide (CGRP), a pro-inflammatory polypeptide implicated in migraine pathology, by targeting its receptor.
M. Armanious +3 more
semanticscholar +1 more source
Chronic migraine: Classification and comparisons
Cephalalgia, 2011Objective: The objective of our study was to field test different chronic migraine (CM) criteria and compare CM epidemiological profiles, which include demographic, personal, and lifestyle characteristics, with high-frequency episodic migraine (HFEM) and low-frequency episodic migraine (LFEM). Methods: Questionnaires were mailed to a random sample of
Katsarava, Zaza +8 more
openaire +2 more sources